New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
07:07 EDTCBLICleveland BioLabs subsidiary signs contract for about $4.6M with Russia
Cleveland BioLabs and Panacela Labs announced award of a contract valued at 146 million rubles, or approximately $4.6M with the Ministry of Industry and Trade of the Russian Federation for development of Xenomycins, a family of compounds in development as anti-infective agents. The contract, issued under the Russian Federation's "Pharma 2020" development initiative, provides matching funding over a period of approximately three years, which will be used to support preclinical and clinical studies.
News For CBLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
15:46 EDTCBLIASCO gives Cleveland BioLabs stage for lead drug, Buffalo Business First says
Cleveland BioLabs' poster presentation this Saturday, May 30, on its lead drug candidate during the American Society of Clinical Oncology meeting will give the therapy a "national stage," according to Buffalo Business First. Shares of micro-cap Cleveland BioLabs are up 60% to $3.09 in late day trading. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use